Mortality occurred in 8% of patients. Forty percent of the deaths were directly related to the bleeding episode, whilst the remaining deaths were associated with co-morbidities. Mortality is similar to that reported in PUB without liver cirrhosis. Despite recent improvement in PUB management, mortality of PUB remains high, ranging from 5% to 10%.20 Co-morbidity is an important predictor of death in all patients with gastro intestinal bleeding, in a recently published study of 10,428 patients with NVUGIB in non-cirrhotic patients, death was associated with causes directly related to the bleeding episode in only 29% of cases whilst in the remaining cases, co-morbidity played a fundamental role.